Simcere Pharmaceutical Group Ltd
Simcere Pharmaceutical Group's GHG Emissions Data Preview
In 2023, Simcere Pharmaceutical Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Simcere Pharmaceutical Group has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Simcere Pharmaceutical Group's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Simcere Pharmaceutical Group amounted to 67,632.68 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Simcere Pharmaceutical Group decreased by 2.34%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
Simcere Pharmaceutical Group's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Simcere Pharmaceutical Group's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Simcere Pharmaceutical Group were 4,996.5 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Simcere Pharmaceutical Group reduced its Scope 1 emissions over time?
Since 2020, Simcere Pharmaceutical Group's Scope 1 emissions have increased by 3.68%, reflecting a rising long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), Simcere Pharmaceutical Group's Scope 1 emissions decreased by 5.38%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.
What are Simcere Pharmaceutical Group's Scope 2 emissions?
In 2023, Simcere Pharmaceutical Group reported Scope 2 greenhouse gas (GHG) emissions of 62,636.18 tCOâ‚‚e without specifying the calculation method.
Has Simcere Pharmaceutical Group reduced its Scope 2 emissions over time?
Since 2020, Simcere Pharmaceutical Group's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Simcere Pharmaceutical Group 's emissions have plateaued with no significant change in its energy consumption footprint.
Compared to the previous year (2022), Simcere Pharmaceutical Group's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Simcere Pharmaceutical Group 's emissions have plateaued with no significant change in its energy consumption footprint.
What methodology does Simcere Pharmaceutical Group use for Scope 2 reporting?
In 2023, Simcere Pharmaceutical Group reported its Scope 2 emissions using an unspecified methodology.
Simcere Pharmaceutical Group's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)